Plus Therapeutics (PSTV) Misses Q3 EPS by 4c
Plus Therapeutics (NASDAQ: PSTV) reported Q3 EPS of ($0.04). Revenue for the quarter came in at $1.4 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.
Plus Therapeutics (NASDAQ: PSTV) reported Q3 EPS of ($0.04). Revenue for the quarter came in at $1.4 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.